부산대학교 도서관

Zhu, Xiaoyan ; Coleman, Ruth A ; Alber, Carol ; Ballas, Zuhair K ; Waldschmidt, Thomas J ; Ray, Nancy B ; Krieg, Arthur M ; Cook, Robert T

In Alcohol 2004 32(2):91-100

Krieg, Arthur M

In Trends in Microbiology 2001 9(6):249-252

Krieg, Arthur M

In Vaccine 8 November 2000 19(6):618-622

Krieg, Arthur M ; Kline, Joel N

In Immunopharmacology 25 July 2000 48(3):303-305

Krieg, Arthur M

In Current Opinion in Immunology 1 February 2000 12(1):35-43

McCluskie, Michael J ; Weeratna, Risini D ; Krieg, Arthur M ; Davis, Heather L

In Vaccine 2000 19(7):950-957

Krieg, Arthur M ; Wagner, Hermann

In Immunology Today 2000 21(10):521-526

J Immunother Cancer

Milhem MM; University of Iowa, Iowa City, Iowa, USA.; Zakharia Y; University of Iowa, Iowa City, Iowa, USA.; Davar D; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.; Buchbinder EI; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Medina T; University of Colorado Denver, Aurora, Colorado, USA.; Daud A; University of California San Francisco, San Francisco, California, USA.; Ribas A; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.; Chmielowski B; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.; Niu J; Banner MD Anderson Cancer Center, Gilbert, Arizona, USA.; Gibney GT; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, USA.; Margolin K; Saint John's Cancer Institute, Santa Monica, California, USA.; Olszanski AJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Mehmi I; The Angeles Clinic and Research Institute, Cedars-Sinai Affiliate, Los Angeles, California, USA.; Sato T; Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Shaheen M; The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.; Zhao L; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Kelley H; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Liu H; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Kumar S; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Bobilev D; Fusion Pharmaceuticals, Boston, Massachusetts, USA.; Krieg AM; Zola Therapeutics, Needham, Massachusetts, USA.; Wooldridge JE; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Kirkwood JM; Hillman Cancer Center, University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Krieg, Arthur M

In Molecular Therapy - Nucleic Acids 2012 1

Nature Medicine. Jul2003, Vol. 9 Issue 7, p831. 5p.

Lemke, Caitlin D ; Blackwell, Sue E ; Krieg, Arthur M ; Salem, Aliasger ; Weiner, George J

In Blood 2 December 2016 128(22):3023-3023

Nature Immunology. May2010, Vol. 11 Issue 5, p367-369. 3p. 1 Diagram.

Nature Immunology. May2007, Vol. 8 Issue 5, p475-477. 3p.

Uhlik M; OncXerna Therapeutics, Inc., Waltham, MA, United States.; Pointing D; Genialis, Inc., Boston, MA, United States.; Iyer S; OncXerna Therapeutics, Inc., Waltham, MA, United States.; Ausec L; Genialis, Inc., Boston, MA, United States.; Štajdohar M; Genialis, Inc., Boston, MA, United States.; Cvitkovič R; Genialis, Inc., Boston, MA, United States.; Žganec M; Genialis, Inc., Boston, MA, United States.; Culm K; OncXerna Therapeutics, Inc., Waltham, MA, United States.; Santos VC; OncXerna Therapeutics, Inc., Waltham, MA, United States.; Pytowski B; OncXerna Therapeutics, Inc., Waltham, MA, United States.; Malafa M; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.; Liu H; Checkmate Pharmaceuticals, Inc., Cambridge, MA, United States.; Krieg AM; Checkmate Pharmaceuticals, Inc., Cambridge, MA, United States.; Lee J; Department of Hematology and Oncology, Samsung Medical Center, Seoul, Republic of Korea.; Rosengarten R; Genialis, Inc., Boston, MA, United States.; Benjamin L; OncXerna Therapeutics, Inc., Waltham, MA, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Davar D; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: davard@upmc.edu.; Morrison RM; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA.; Dzutsev AK; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Karunamurthy A; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Department of Dermatology, University of Pittsburgh, Pittsburgh, PA, USA.; Chauvin JM; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Amatore F; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.; Deutsch JS; Division of Dermatopathology, Johns Hopkins University, Baltimore, MD, USA.; Das Neves RX; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.; Rodrigues RR; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA; Genetics and Microbiome Core, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; McCulloch JA; Genetics and Microbiome Core, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Wang H; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.; Hartman DJ; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.; Badger JH; Genetics and Microbiome Core, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Fernandes MR; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Bai Y; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, USA.; Sun J; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, USA.; Cole AM; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Aggarwal P; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Fang JR; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Deitrick C; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Bao R; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.; Duvvuri U; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA.; Sridharan SS; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA.; Kim SW; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA.; A Choudry H; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.; Holtzman MP; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.; Pingpank JF; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.; O'Toole JP; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Division of Plastic Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.; DeBlasio R; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Jin Y; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Ding Q; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Gao W; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Groetsch C; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Pagliano O; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Rose A; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Urban C; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Singh J; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.; Divarkar P; Nanostring Technologies, Seattle, WA, USA.; Mauro D; Checkmate Pharmaceuticals, Cambridge, MA, USA.; Bobilev D; Checkmate Pharmaceuticals, Cambridge, MA, USA.; Wooldridge J; Checkmate Pharmaceuticals, Cambridge, MA, USA.; Krieg AM; Checkmate Pharmaceuticals, Cambridge, MA, USA.; Fury MG; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.; Whiteaker JR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Zhao L; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Paulovich AG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Najjar YG; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.; Luke JJ; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.; Kirkwood JM; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.; Taube JM; Division of Dermatopathology, Johns Hopkins University, Baltimore, MD, USA; Tumor Microenvironment Core, Bloomberg-Kimmel Institute of Immunotherapy, Mark Foundation Center for Advanced Imaging and Genomics, Johns Hopkins University, Baltimore, MD, USA.; Park HJ; Department of Dermatology, University of Pittsburgh, Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.; Trinchieri G; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address: trinchig@mail.nih.gov.; Zarour HM; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA; Department of Dermatology, University of Pittsburgh, Pittsburgh, PA, USA; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: zarourhm@upmc.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Trends in Immunology. 23(2):64-65

Negrao, Marcelo V; Papadimitrakopoulou, Vassiliki A; Price, Andrew C; Tam, Alda L; Furqan, Muhammad; Laroia, Sandeep T; Massarelli, Erminia; Pacheco, Jose; Heymach, John V; Tsao, Anne S; Walker, Gary V; Vora, Lalit; Mauro, David; Kelley, Heather; Wooldridge, James E; Krieg, Arthur M; Niu, Jiaxin

JTO Clin Res Rep
JTO Clinical and Research Reports, Vol 4, Iss 3, Pp 100423-(2023)

Cooper, Curtis L; Davis, Heather L; Angel, Jonathan B; Morris, Mary Lou; Elfer, Sue M; Seguin, Isabelle; Krieg, Arthur M; Cameron, D William

AIDS (02699370); Sep2005, Vol. 19 Issue 14, p1473-1479, 7p

Goyenvalle A; Université Paris-Saclay, UVSQ, Inserm, END-ICAP, Versailles, France.; Jimenez-Mallebrera C; Laboratorio de Investigación Aplicada en Enfermedades Neuromusculares, Unidad de Patología Neuromuscular, Servicio de Neuropediatría, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.; Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Departamento de Genética, Microbiología y Estadística, Universitat de Barcelona, Barcelona, Spain.; van Roon W; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.; Sewing S; Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.; Krieg AM; RNA Therapeutics Institute, University of Massachusetts, Worcester, Massachusetts, USA.; Arechavala-Gomeza V; Neuromuscular Disorders, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.; Andersson P; Safety Innovation, Safety Sciences, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.

Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-3345 (Electronic) Linking ISSN: 21593337 NLM ISO Abbreviation: Nucleic Acid Ther Subsets: MEDLINE